Journal
/
Bioengineering
/
Automatiseret Sammentrækning Analyse af humant Engineered Heart Væv til Cardiac Drug Safety Screening
JoVE Journal
Bioengineering
A subscription to JoVE is required to view this content.  Sign in or start your free trial.
JoVE Journal Bioengineering
Automated Contraction Analysis of Human Engineered Heart Tissue for Cardiac Drug Safety Screening

Automatiseret Sammentrækning Analyse af humant Engineered Heart Væv til Cardiac Drug Safety Screening

DOI:
10.3791/55461-v

•

10:39 min

•

April 15, 2017

•

, , , , , ,
1Department of Experimental Pharmacology and Toxicology, Cardiovascular Research Center,University Medical Center Hamburg-Eppendorf and DZHK (German Center for Cardiovascular Research)

Chapters

  • 00:05Title
  • 01:05Engineering Heart Tissue (EHT) Generation
  • 03:40Contraction Analysis
  • 05:48Drug Screening
  • 08:20Results: Representative EHT Contraction Analysis
  • 09:32Conclusion

Summary

Automatic Translation

Automatic Translation

Her viser vi genereringen af ​​human manipuleret hjertevæv fra inducerede pluripotente stamceller (hiPSC) afledt cardiomyocytter. Vi præsenterer en metode til at analysere kontraktionskraft og eksemplarisk ændring af sammentrækning mønster af hERG kanal inhibitor E-4031. Denne metode viser høj grad af robusthed og egnethed til hjerte- lægemiddelscreening.

Tags

Cardiac Drug Safety ScreeningContractile ForceIn Vitro Contraction AnalysisDisease ModelingSafety PharmacologyGene VariantsAgarosePDMS RacksCardiomyocytesFibrinogenThrombinEHT Medium

Article

Embed

ADD TO PLAYLIST

Usage Statistics

Related Videos

Bioluminescence Imaging for Assessment of Immune Responses Following Implantation of Engineered Heart Tissue (EHT)

Selvrapportering Stilladser for 3-Dimensional Cell Culture

Analyse af Tubular Membrane Networks i hjertemyocytter fra Atria og hjertekamre

Hul fiber Bioreaktorer for<em> In vivo</em> -lignende Pattedyr Tissue Culture

Konstruktion af Defineret Humane Engineered hjertevæv at studere Mekanismer for Cardiac Cell Therapy

En kombineret 3D manipuleret væv<em> In vitro</em> /<em> I Silico</em> Lunge Tumor Model for Forudsigelse Drug Effektivitet i specifikke mutations baggrunde

Neonatal Cardiac Stilladser: Nye Matricer til regenerativ Studies

Brug af høj overførselshastighed automatiseret Microbioreactor System for produktion af Model IgG1 i CHO celler

Forberedelse af mesh-formet manipuleret hjertevæv stammer fra humane iPS-celler til In Vivo Myokardiereparation

Cardiac Sfæroider som in vitro Bioengineered hjertevæv at studere Human Heart Patofysiologi

Read Article